Tuberculosis and treatment with infliximab.
Zhang
Zili
Z
Correa
Hernán
H
Bégué
Rodolfo E
RE
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000276:immunology; D003424:Crohn Disease / Q000188:drug therapy; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006660:Histoplasmosis / Q000139:chemically induced*; D006801:Humans; D000069285:Infliximab; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab